C-620-0696

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameC-620-0696
Drug Alias NameC-620-0696C620-0696
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain PHD finger transcription factor inhibitors
TargetsBromodomain PHD finger transcription factor
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMacau University of Science and Technology
China Registration ClassN/A

Develop Information

Active CompaniesMacau University of Science and Technology
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A